You are here

Article Text

Article menu

Download PDFPDF

Plenary sessions
Plenary 5
IGCS19-0176
32 Role of adjuvant external beam radiotherapy in stage ii endometrial cancer: a systematic review and meta-analysis
Free
  1. D Narasimhulu1,
  2. AG Cope2,
  3. IA Petersen3,
  4. WA Cliby1,
  5. CL Langstraat1,
  6. GE Glaser1,
  7. A Kumar1,
  8. S Cappuccio4 and
  9. A Mariani1
  1. 1Mayo Clinic, Division of Gynecologic Surgery, Rochester, USA
  2. 2Mayo Clinic, Division of Gynecology, Rochester, USA
  3. 3Mayo Clinic, Department of Radiation Oncology, Rochester, USA
  4. 4Fondazione Policlinico Universitario “Agostino Gemelli”- IRCCS- Università Cattolica del Sacro Cuore, Department of Woman’s and Child Health, Rome, Italy

Abstract

Objectives To summarize the evidence on adjuvant postoperative external beam radiotherapy (EBRT) when compared to vaginal brachytherapy (VBT) alone on survival and recurrence in women with stage II endometrial cancer (EC) defined by cervical stromal invasion.

Methods We searched MEDLINE, EMBASE, CENTRAL and Scopus through January 2019 for studies evaluating EBRT±VBT and VBT alone in stage II EC. Study selection, assessment and data abstraction were performed in duplicate. Random-effects models were used to synthesize quantitative data.

Results Fifteen cohort studies reporting data for 1070 women were included. Subgroup analysis by pelvic lymph node evaluation (sampling or full dissection) status (PLNE) was performed. We observed a statistically significant reduction in local recurrence with EBRT±VBT when compared to VBT alone (12 studies, 889 patients, OR:0.34, 95%CI:0.16–0.72, I2=0%) for women with stage II EC regardless of PLNE (figure 1). EBRT±VBT was associated with statistically significant reduction in mortality compared to VBT only for the subgroup who underwent PLNE (2 studies, 252 patients, OR:0.41, 95%CI:0.17–0.99, I2=0%). It was not possible to evaluate the additional morbidity with EBRT and benefit of chemotherapy in this population.

Abstract 32 Figure 1
Abstract 32 Figure 1

Conclusions EBRT±VBT resulted in decreased local recurrence for stage II EC regardless of PLNE status and a survival benefit only for the subgroup that underwent PLNE. These conclusions are based on observational studies warranting limited certainty. However, given the lack of, and limited prospect of acquiring prospective data in the near future, EBRT±VBT must be considered in all patients with stage II EC.

https://doi.org/10.1136/ijgc-2019-IGCS.32

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.